or Try an Advanced Search...

    Technical Analysis for BCTX - BriaCell Therapeutics Corp.

    Grade Last Price % Change Price Change
    F 0.79 -2.30% -0.02
    BCTX closed down 2.3 percent on Friday, November 1, 2024, on 5 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical BCTX trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    MACD Bearish Centerline Cross Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Crossed Above 50 DMA Bullish -2.30%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.30%
    Inside Day Range Contraction -2.30%
    Wide Bands Range Expansion -2.30%
    Fell Below 50 DMA Bearish 3.20%
    Expansion Pivot Sell Setup Bearish Swing Setup 3.20%
    Older End-of-Day Signals for BCTX ...

       Recent Intraday Alerts

    Alert Time
    Down 3% 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    Down 2 % 1 day ago
    Fell Below 50 DMA 1 day ago
    50 DMA Support 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BCTX Chart by TradingView
    Basic chart:

    Profile

    BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer

    Is BCTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 22 BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns
    Oct 22 BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study
    Oct 22 BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
    Oct 15 BriaCell gains after update on late-stage trial for lead asset
    Oct 15 BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
    Oct 2 BriaCell Therapeutics Announces Closing of $5 Million Offering
    Oct 2 Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
    Oct 1 BriaCell Therapeutics Announces $5 Million Offering
    Oct 1 BriaCell dips despite promising mid-stage data for breast cancer therapy
    Oct 1 BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor
    See more BCTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.97
    52 Week Low 0.4641
    Average Volume 6,203,158
    200-Day Moving Average 1.78
    50-Day Moving Average 0.80
    20-Day Moving Average 0.89
    10-Day Moving Average 0.84
    Average True Range 0.11
    RSI (14) 46.52
    ADX 26.08
    +DI 22.49
    -DI 20.02
    Chandelier Exit (Long, 3 ATRs) 0.86
    Chandelier Exit (Short, 3 ATRs) 1.06
    Upper Bollinger Bands 1.06
    Lower Bollinger Band 0.72
    Percent B (%b) 0.21
    BandWidth 38.09
    MACD Line 0.00
    MACD Signal Line 0.01
    MACD Histogram -0.0185
    Fundamentals Value
    Market Cap 12.7 Million
    Num Shares 16 Million
    EPS -1.73
    Price-to-Earnings (P/E) Ratio -0.46
    Price-to-Sales 0.00
    Price-to-Book 23.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.87
    Resistance 3 (R3) 0.87 0.85 0.86
    Resistance 2 (R2) 0.85 0.83 0.85 0.85
    Resistance 1 (R1) 0.82 0.82 0.81 0.82 0.85
    Pivot Point 0.80 0.80 0.80 0.80 0.80
    Support 1 (S1) 0.77 0.78 0.76 0.77 0.74
    Support 2 (S2) 0.75 0.77 0.75 0.74
    Support 3 (S3) 0.72 0.75 0.73
    Support 4 (S4) 0.72